These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1288538)

  • 1. [Fluorocarbon emulsions as injectable oxygen carriers. Recent progress and perspectives].
    Riess JG
    Rev Fr Transfus Hemobiol; 1992 Dec; 35(6):391-406. PubMed ID: 1288538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery.
    Riess JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):183-202. PubMed ID: 1391434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorocarbon-based in vivo oxygen transport and delivery systems.
    Riess JG
    Vox Sang; 1991; 61(4):225-39. PubMed ID: 1776239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorocarbon-based oxygen carriers: new orientations.
    Riess JG
    Artif Organs; 1991 Oct; 15(5):408-13. PubMed ID: 1741687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorocarbon emulsions: methodology to assess efficacy.
    Rosen AL; Sehgal LR; Gould SA; Sehgal H; Dalton L; Rice CL; Moss GS
    Crit Care Med; 1982 Mar; 10(3):149-54. PubMed ID: 7060386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorocarbon emulsions--the stability issue.
    Postel M; Riess JG; Weers JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):991-1005. PubMed ID: 7849970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The design and development of improved fluorocarbon-based products for use in medicine and biology.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):215-34. PubMed ID: 8087244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
    Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced fluorocarbon-based systems for oxygen and drug delivery, and diagnosis.
    Riess JG; Krafft MP
    Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):43-52. PubMed ID: 9083625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes.
    Clark LC; Hoffmann RE; Davis SL
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1085-99. PubMed ID: 1391430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biophysical mechanisms of toxicity of fluorocarbon emulsions].
    Obratsov VV; Tarakhovskiĭ IuS; Ponomarchuk VV; Sklifas AN
    Biofizika; 1994; 39(4):732-7. PubMed ID: 7981282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of fluorocarbon-in-water emulsions with added triglyceride.
    Weers JG; Arlauskas RA; Tarara TE; Pelura TJ
    Langmuir; 2004 Aug; 20(18):7430-5. PubMed ID: 15323486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorochemical-based artificial oxygen carrying red cell substitutes.
    Lane TA
    Transfus Sci; 1995 Mar; 16(1):19-31. PubMed ID: 10155703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions.
    Remy B; Deby-Dupont G; Lamy M
    Br Med Bull; 1999; 55(1):277-98. PubMed ID: 10695091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic preservation of organs using a new perflubron/lecithin emulsion stabilized by molecular dowels.
    Voiglio EJ; Zarif L; Gorry FC; Krafft MP; Margonari J; Martin X; Riess J; Dubernard JM
    J Surg Res; 1996 Jul; 63(2):439-46. PubMed ID: 8661239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and mechanism of side-effects of Oxygent HT (highly concentrated fluorocarbon emulsion) in swine.
    Flaim SF; Hazard DR; Hogan J; Peters RM
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1511-5. PubMed ID: 7849964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oxygen delivery by perflubron emulsion during acute hemodilution.
    Keipert PE; Faithfull NS; Bradley JD; Hazard DY; Hogan J; Levisetti MS; Peters RM
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1161-7. PubMed ID: 7849918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fluorocarbon emulsion on 24-hour canine heart preservation by coronary perfusion.
    Gohra H; Mori F; Esato K
    Ann Thorac Surg; 1989 Jul; 48(1):96-103. PubMed ID: 2764606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.